Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marine Alves-Ferreira"'
Autor:
A Floquet, Gilles Freyer, Catherine Mercier, Benoit You, J. P. Lotz, J. Massardier, P Descargues, Adeline Roux, P. Rousset, D Grazziotin –soares, Carole Langlois-Jacques, P.-A. Bolze, L. Gladieff, François Golfier, T Hajri, Sylvie Bin, Marine Alves-Ferreira, Laurent Villeneuve
Publikováno v:
Trophoblastic diseases.
Introduction/Background* In patients with gestational trophoblastic tumors (GTT) with a FIGO score ≥ 7, or GTT resistant to both standard monotherapies, the recommended polychemotherapy regimen is EMA-CO. In case of resistance to polychemotherapy,
Autor:
Marine Alves-Ferreira, Jean-Pierre Lotz, Adeline Roux, Touria Hajri, D. Grazziotin-Soares, J. Massardier, Pascal Rousset, Catherine Mercier, Delphine Maucort-Boulch, François Golfier, Laurent Villeneuve, Florence Joly, Gilles Freyer, Benoit You, Laurence Gladieff, Sylvie Bin, Pierre-Adrien Bolze
Publikováno v:
Annals of Oncology. 31:823-825
Autor:
Sylvie Bin, Touria Hajri, Laurence Gladieff, Gilles Freyer, Jérôme Massardier, Daniele Grazziotin, Benoit You, Catherine Mercier, Pascal Rousset, Adeline Roux, Laurent Villeneuve, Pierre-Adrien Bolze, Delphine Maucort-Boulch, Marine Alves-Ferreira, François Golfier, Jean-Pierre Lotz, Florence Joly
Publikováno v:
Journal of Clinical Oncology. 38:LBA6008-LBA6008
LBA6008 Background: Patients with gestational trophoblastic tumors (GTT) resistant to monochemotherapy are treated with historic chemotherapy regimens known to be effective, but toxic. PD-L1 is constitutively expressed in all GTT subtypes (Bolze et a